AU7457594A - New combination of active substances containing esupron and levodopa - Google Patents
New combination of active substances containing esupron and levodopaInfo
- Publication number
- AU7457594A AU7457594A AU74575/94A AU7457594A AU7457594A AU 7457594 A AU7457594 A AU 7457594A AU 74575/94 A AU74575/94 A AU 74575/94A AU 7457594 A AU7457594 A AU 7457594A AU 7457594 A AU7457594 A AU 7457594A
- Authority
- AU
- Australia
- Prior art keywords
- esupron
- levodopa
- active substances
- new combination
- substances containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4325435A DE4325435A1 (en) | 1993-07-29 | 1993-07-29 | New combination of active ingredients |
DE4325435 | 1993-07-29 | ||
PCT/EP1994/002196 WO1995003796A1 (en) | 1993-07-29 | 1994-07-05 | New combination of active substances containing esupron and levodopa |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7457594A true AU7457594A (en) | 1995-02-28 |
Family
ID=6493978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU74575/94A Withdrawn AU7457594A (en) | 1993-07-29 | 1994-07-05 | New combination of active substances containing esupron and levodopa |
Country Status (5)
Country | Link |
---|---|
AU (1) | AU7457594A (en) |
DE (1) | DE4325435A1 (en) |
HR (1) | HRP940429A2 (en) |
IL (1) | IL110336A0 (en) |
WO (1) | WO1995003796A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7208010B2 (en) | 2000-10-16 | 2007-04-24 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
US20040254635A1 (en) | 1998-03-30 | 2004-12-16 | Shanley John F. | Expandable medical device for delivery of beneficial agent |
US6241762B1 (en) | 1998-03-30 | 2001-06-05 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
EP2292190B1 (en) | 2000-10-16 | 2017-11-08 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3243158A1 (en) * | 1982-11-23 | 1984-05-24 | Basf Ag, 6700 Ludwigshafen | NEW SULPHONIC ACID ESTERS OF HYDROXYCUMARINES, THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THEM |
ATE76747T1 (en) * | 1986-06-10 | 1992-06-15 | Chiesi Farma Spa | PHARMACEUTICAL COMPOSITIONS CONTAINING LEVODOPA METHYL ESTER, THEIR PREPARATION AND THERAPEUTIC USES. |
-
1993
- 1993-07-29 DE DE4325435A patent/DE4325435A1/en not_active Withdrawn
-
1994
- 1994-07-05 WO PCT/EP1994/002196 patent/WO1995003796A1/en active Application Filing
- 1994-07-05 AU AU74575/94A patent/AU7457594A/en not_active Withdrawn
- 1994-07-15 IL IL11033694A patent/IL110336A0/en unknown
- 1994-07-27 HR HRP4325435.7A patent/HRP940429A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE4325435A1 (en) | 1995-02-02 |
IL110336A0 (en) | 1994-10-21 |
WO1995003796A1 (en) | 1995-02-09 |
HRP940429A2 (en) | 1997-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1034646A1 (en) | Composition of fungicidally active compounds and its use | |
AU6709596A (en) | Amide compounds and use of the same | |
AU673703B2 (en) | Injector and use of the same | |
AU6201194A (en) | Container and its application | |
ZA945720B (en) | Electrode and preparation thereof | |
ZA939416B (en) | Modified lipolytic enzymes and their use | |
AU1313995A (en) | Composition of polyketone and polyolefin | |
AU4266596A (en) | Composition and use | |
AU5131493A (en) | Improved semiconductor architecture and application therefor | |
PL323103A1 (en) | Composition containing amoxycyclin and clavulanic acid | |
PL312835A1 (en) | Changing composition and methods of its application | |
AU3047792A (en) | Combinations of herbicides and crop-protecting substances | |
ZA939415B (en) | Modified lipolytic enzymes and their use | |
AU6160594A (en) | Diabetes prevention and treatment | |
HU9402361D0 (en) | New makrolides and use of them | |
AU6995594A (en) | Aryltriflates and related compounds | |
AU6369094A (en) | Ige isoforms and methods of use | |
AU4100593A (en) | Iminoalcohol-oxazolidine mixtures and their use | |
AU6723294A (en) | Use of simmondsine | |
SG46705A1 (en) | Solutions of polyimide-forming substances and their use | |
AU7457594A (en) | New combination of active substances containing esupron and levodopa | |
AU2940895A (en) | Use of insulin and igf-i | |
AU7297594A (en) | Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines | |
AU7352396A (en) | Use of protein S-100b in medicines and medicines containing the protein S-100-b | |
AU6376694A (en) | New use of a combination of verapamil and trandolapril |